Form 4: Eli Lilly Executive Ilya Yuffa Reports Stock Transactions
SEC Form 4 Filing
EVP & President of Eli Lilly International, Ilya Yuffa, reports acquisition and disposal of common stock and acquisition of restricted stock units.
Summary
- Ilya Yuffa, EVP & President of Eli Lilly International, filed a Form 4 detailing changes in beneficial ownership of Eli Lilly & Co [LLY] securities.
- On February 10, 2025, Yuffa acquired 7,123.348 shares of common stock at a price of $868.88 per share.
- Following the transaction, Yuffa directly owns 28,759.971 shares of common stock.
- Additionally, Yuffa acquired 3,394 restricted stock units, each representing a contingent right to receive one share of Eli Lilly common stock, exercisable and expiring on February 1, 2026.
- The reported transactions were signed off by Jonathan Groff on February 12, 2025, pursuant to authorization on file.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of common stock and restricted stock unit transaction |
| 02/01/2026 | Exercisable and Expiration date of restricted stock units |
| 02/12/2025 | Date of signature by Jonathan Groff |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.